Page last updated: 2024-08-23

pyrrolidine and Obesity

pyrrolidine has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatt, UR; Bleasby, K; Chabin, RM; Chen, D; Chen, Q; Colletti, SL; Garcia-Calvo, M; Geissler, WM; Graham, TH; Hale, JJ; He, H; Lassman, ME; Liu, W; Pinto, S; Shen, DM; Shen, HC; Shen, Z; Tata, JR; Tong, X; Tung, EC; Verras, A; Xie, D; Xiong, Y; Xu, S1
Bhatt, UR; Bleasby, K; Chen, Q; Garcia-Calvo, M; Geissler, WM; Gorski, JN; Graham, TH; Hale, JJ; He, H; Lassman, ME; Li, X; Lisnock, J; Liu, W; Pinto, S; Sebhat, IK; Shen, DM; Shen, Z; Tong, X; Tung, EC; Verras, A; Wiltsie, J; Xiao, J; Xie, D; Xiong, Y; Xu, S1

Other Studies

2 other study(ies) available for pyrrolidine and Obesity

ArticleYear
The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors.
    Bioorganic & medicinal chemistry letters, 2012, Jan-01, Volume: 22, Issue:1

    Topics: Amides; Animals; ATP Binding Cassette Transporter, Subfamily B; Benzimidazoles; Biological Transport; Body Weight; Brain; Carboxypeptidases; Disease Models, Animal; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; Obesity; Pyrrolidines; Time Factors

2012
A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluation.
    Bioorganic & medicinal chemistry letters, 2012, Apr-15, Volume: 22, Issue:8

    Topics: Animals; Butanols; Carboxypeptidases; Drug Discovery; Enzyme Activation; Enzyme Inhibitors; Inhibitory Concentration 50; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Obesity; Pyrrolidines

2012